DL

David Lustig

Active Director Director DIN 10735829
DIN 10735829 First appointment Aug 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About David Lustig

Data last updated:

David Lustig is a Director at Degania Medical Devices Private Limited (since 2024). The company operates in Healthcare. Degania Medical Devices Private Limited reported revenue of ₹205 Cr (FY 2025).

DIN 10735829
Primary Designation Director
Industry Healthcare
First Appointment 20 Aug 2024
Oldest Company Age 22 yrs
Largest company Degania Medical Devices Private Limited · ₹205 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Aug 20242004₹205 Cr (FY 2025)Active

Board colleagues of David Lustig

Directorship timeline

Open interactive timeline →
Degania Medical Devices Private Limited
Premium access

Shareholding and investment profile for David Lustig

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about David Lustig

David Lustig currently holds 1 directorship: Degania Medical Devices Private Limited (Director, since 20 Aug 2024, revenue ₹205 Cr (FY 2025)).

David Lustig was first appointed on 20 Aug 2024 as Director at Degania Medical Devices Private Limited.

The current boards of David Lustig's companies include Mauricio Arellano (Degania Medical Devices Private Limited), Vikas Bhardwaj (Degania Medical Devices Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available